European Healthtech startup funding raised during September 2020.
In September 2020, 65 European Healthtech companies raised a combined €944M across 66 funding rounds, down 2.4% versus September 2019. Switzerland led by capital raised, and aMoon Fund was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Sophia Genetics | Series D+ | Sep 2020 | €94M |
| Neogene Therapeutics | Other | Sep 2020 | €93M |
| Lava Therapeutics | Series C | Sep 2020 | €70M |
| Melio | Series C |
| Acquisition |
| Sep 2020 |
| €60M |
| Sep 2020 |
| €68M |
| Imcheck Therapeutics | Other | Sep 2020 | €54M |
| Orasis Pharmaceuticals | Other | Sep 2020 | €25M |
| Bima | Other | Sep 2020 | €25M |
| Medigate | Series B | Sep 2020 | €25M |
| MiNA Therapeutics | Series A | Sep 2020 | €25M |
| Miracor Medical | Series D+ | Sep 2020 | €24M |
| V-Wave | Series C | Sep 2020 | €24M |
| NBE-Therapeutics | Other | Sep 2020 | €21M |
| Bioprotect | Series D+ | Sep 2020 | €21M |
| Cycle Pharmaceuticals | Debt | Sep 2020 | €21M |
| Numab | Series B | Sep 2020 | €20M |
